Quest Diagnostics, Inc.’s recent filing unveils that its SVP & Chief Commercial Officer DELANEY MARK E unloaded Company’s shares for reported $60094.0 on Jul 24 ’24. In the deal valued at $143.08 per share,420 shares were sold. As a result of this transaction, DELANEY MARK E now holds 5,019 shares worth roughly $0.76 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, KUPPUSAMY KARTHIK sold 1,760 shares, generating $246,400 in total proceeds. Upon selling the shares at $140.00, the SVP, Clinical Solutions now owns 13,435 shares.
Before that, Doherty Catherine T. sold 5,557 shares. Quest Diagnostics, Inc. shares valued at $703,349 were divested by the EVP, Regional Businesses at a price of $126.57 per share. As a result of the transaction, Doherty Catherine T. now holds 69,599 shares, worth roughly $10.52 million.
Citigroup upgraded its Quest Diagnostics, Inc. [DGX] rating to a Buy from a a Neutral in a research note published on July 10, 2024; the price target was increased to $165 from $145. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”a Market perform”‘ rating. Jefferies also remained covering DGX and has increased its forecast on February 07, 2024 with a “Buy” recommendation from previously “Hold” rating. Barclays started covering the stock on January 03, 2024. It rated DGX as “an Equal weight”.
Price Performance Review of DGX
On Monday, Quest Diagnostics, Inc. [NYSE:DGX] saw its stock fall -0.17% to $151.12. Over the last five days, the stock has gained 0.47%. Quest Diagnostics, Inc. shares have risen nearly 9.60% since the year began. Nevertheless, the stocks have risen 14.28% over the past one year. While a 52-week high of $152.00 was reached on 08/19/24, a 52-week low of $119.59 was recorded on 02/01/24. SMA at 50 days reached $143.32, while 200 days put it at $135.89.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 150.13, which if violated will result in even more drops to 149.15. On the upside, there is a resistance level at 152.49. A further resistance level may holdings at 153.87. The Relative Strength Index (RSI) on the 14-day chart is 60.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.05, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.46%. Stochastics%K at 86.53% indicates the stock is a selling.
How much short interest is there in Quest Diagnostics, Inc.?
A steep rise in short interest was recorded in Quest Diagnostics, Inc. stocks on 2024-07-31, growing by 63228.0 shares to a total of 2.33 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 2.27 million shares. There was a rise of 2.71%, which implies that there is a positive sentiment for the stock.
